Tailored pharmacokinetic dosing allows self-administration and reduces the cost of IV augmentation therapy with human alpha(1)-antitrypsin.
Piitulainen, Eeva
Tailored pharmacokinetic dosing allows self-administration and reduces the cost of IV augmentation therapy with human alpha(1)-antitrypsin. [electronic resource] - European journal of clinical pharmacology Jun 2003 - 151-6 p. digital
Publication Type: Clinical Trial; Journal Article; Research Support, Non-U.S. Gov't
0031-6970
10.1007/s00228-003-0589-z doi
Aged
Drug Administration Schedule
Female
Half-Life
Humans
Infusions, Intravenous
Male
Middle Aged
Self Administration
Time Factors
alpha 1-Antitrypsin--administration & dosage
alpha 1-Antitrypsin Deficiency--drug therapy
Tailored pharmacokinetic dosing allows self-administration and reduces the cost of IV augmentation therapy with human alpha(1)-antitrypsin. [electronic resource] - European journal of clinical pharmacology Jun 2003 - 151-6 p. digital
Publication Type: Clinical Trial; Journal Article; Research Support, Non-U.S. Gov't
0031-6970
10.1007/s00228-003-0589-z doi
Aged
Drug Administration Schedule
Female
Half-Life
Humans
Infusions, Intravenous
Male
Middle Aged
Self Administration
Time Factors
alpha 1-Antitrypsin--administration & dosage
alpha 1-Antitrypsin Deficiency--drug therapy